[The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia]. 1976

K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
January 1976, Atherosclerosis,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
November 1979, The New England journal of medicine,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
August 1975, Metabolism: clinical and experimental,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
March 1976, MMW, Munchener medizinische Wochenschrift,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
September 1971, Archives internationales de pharmacodynamie et de therapie,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
January 1970, Pathologica,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
January 1982, Arzneimittel-Forschung,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
February 1977, Metabolism: clinical and experimental,
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
December 1976, Deutsche medizinische Wochenschrift (1946),
K H Vogelberg, and B Althoff, and E M Heggen, and W Thesseling
August 1994, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!